Faron Pharmaceuticals Oy (FARN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 11:31AM BST. Market open.
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 91.81M |
| Enterprise value | 97.17M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 43.27 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.42 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.13 |
| 52-week change 3 | -60.03% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 370.00 |
| 52-week low 3 | 113.00 |
| 50-day moving average 3 | 145.20 |
| 200-day moving average 3 | 258.51 |
Share statistics
| Avg vol (3-month) 3 | 31.37k |
| Avg vol (10-day) 3 | 18.41k |
| Shares outstanding 5 | 72.01M |
| Implied shares outstanding 6 | 72.01M |
| Float 8 | 41.59M |
| % held by insiders 1 | 39.83% |
| % held by institutions 1 | 12.53% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -166.16% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -28.37M |
| Net income avi to common (ttm) | -30.94M |
| Diluted EPS (ttm) | -0.41 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.88M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 13.11M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.59 |
| Book value per share (mrq) | -0.22 |
Cash flow statement
| Operating cash flow (ttm) | -23.81M |
| Levered free cash flow (ttm) | -12.88M |
© 2024 Yahoo. All rights reserved.